Coronado Research
Coronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies through the provision of EDC services, Data Management delivery and Risk-Based Quality Management.
Locations
- Australia
- Europe
- North America
Therapeutic Areas
- Bone / Osteoporosis
- Cardiovascular
- CNS
- Dental and Oral Health
- Dermatology
- Devices and Diagnostics
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Hepatology
- Immunology
- Infectious Diseases
- Inflammation
- Internal Diseases
- Metabolic Diseases
- Musculoskeletal
- Nephrology
- Neurology
- Nutrition and Health
- Obstetrics / Gynecology
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology/ENT (Ear/Nose/Throat)
- Pain / Anesthesia
- Pediatrics / Neonatology
- Pharmacology / Toxicology
- Podiatry
- Psychiatry
- Pulmonary
- Rare Disease
- Respiratory
- Rheumatology
- Sleep
- Surgery
- Thrombosis
- Urology
- Vaccines
- Women's Health
Coronado Research’s objective is to optimise the clinical development process across all phases by leveraging all the data available using AI, ML, and leading technologies, enabling clinical development teams, small or large, to take every advantage available in order to bring more treatments to patients as effectively as possible.
Our diverse expertise spans multiple therapeutic areas, including oncology, rare diseases, cardiovascular, cell and gene therapies, paediatrics, immunology, neurology, and more.
In addition to Clinical Development, our practices cover Digital Innovation, Regulatory, Market Access and HEOR (Health Economics and Outcomes Research), and Medical Affairs. Our teams work with customers to “join-the-dots” between these disciplines to ensure treatments are developed with the end in mind and better match market needs.